David Brindley

Regenerative Medicine: Hype, Hope and Emerging Clinical Realities

David is an international thought-leader in healthcare risk management, with a particular interest in regenerative medicines. His multi-disciplinary research seeks to evaluate and develop systematic, rigorous and transparent risk management tools supporting the translation of life-science innovations into commercially viable products and services.

Buttontwitter Buttonlinkedin
This website uses cookies to ensure you get the best experience. Learn more